The patient continued bleeding around the seal [device ineffective].No additional ae, no pqc reported.[no adverse event].Case narrative: this spontaneous report originating from united states was received from other health care professional (educator) via company representative referring to a female patient of unknown age.The patient¿s historical condition included delivery and pregnancy.The patient¿s concomitant medications and past drug reactions/allergies were not reported.The patient's current condition included lower segment atony.This report concerns 1 patient(s) and 1 device(s).On (b)(6) 2024, the patient was placed with vacuum-induced hemorrhage control system (jada system) via vaginal route (lot #, serial # and expiration date were not reported) for post-partum hemorrhage.On 04-mar-2024, provider placed the vacuum-induced hemorrhage control system (jada system) for post-partum hemorrhage due to lower segment atony.60cc was placed in the cervical seal, and the patient continued bleeding around the seal.The vacuum-induced hemorrhage control system (jada system) was removed, and they moved up their algorithm with treatment.The patient sought medical attention.No product quality complaint (pqc) reported.No additional adverse event (ae) reported (no adverse event).Therapy with vacuum-induced hemorrhage control system (jada system) was discontinued on (b)(6) 2024.Upon internal review, the event device ineffective was determined to be serious due to required intervention (devices).When the lot number is unknown, a technical investigation of the specific manufacturing process which includes review of records associated with a known lot number cannot be performed.Medical device reporting criteria: serious injury.
|